At its January meeting, our safety committee 🔎💊, the #PRAC, recommended aligning dose recommendations for Janus kinase inhibitors for chronic inflammatory disorders.

#chronicillness #SafetyOfMedicines

Read more in our highlights: https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-9-12-january-2023

🐦🔗: https://n.respublicae.eu/EMA_News/status/1613886224040710148